Benign Prostatic Hyperplasia (BPH) Drugs

2017-2025 World Benign Prostatic Hyperplasia (BPH) Drugs Market Research Report (by Product Type, End-User / Application and Regions / Countries)

Report ID: HeyReport 54628 | Number of pages: 129 | Publish Date: Oct 2019 | Category: Lifesciences and Healthcare
This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions.
The report includes as follows:
The report provides current data, historical overview and future forecast.
The report includes an in-depth analysis of the Global market for Benign Prostatic Hyperplasia (BPH) Drugs , covering Global total and major region markets.
The data of 2017-2025 are included. All-inclusive market are given through data on sales, consumption, and prices (Global total and by major regions). 
The report provides introduction of leading Global manufacturers.
Benign Prostatic Hyperplasia (BPH) Drugs market prospects to 2025 are included (in sales, consumption and price).
Market Segment as follows:
By Region / Countries
    North America (U.S., Canada, Mexico)
    Europe (Germany, U.K., France, Italy, Russia, Spain etc)
    Asia-Pacific (China, India, Japan, Southeast Asia etc)
    South America (Brazil, Argentina etc)
    Middle East & Africa (Saudi Arabia, South Africa etc)
By Type
    Alpha-blocker
    Phosphodiesterase Type-5 Inhibitors
    5-alpha-Reductase Inhibitors
By End-User / Application
    Hospitals
    Clinics
    Others
By Company
    Astellas Pharma
    Eli Lilly
    GlaxoSmithKline
    Sanofi
    ADC Therapeutics
    Bayer HealthCare
    Bristol-Myers Squibb
    Valeant Pharmaceuticals
    Endo Pharmaceuticals
    Foresee Pharmaceuticals
    Madrigal Pharmaceuticals
    Merck
    Novartis
    Spectrum Pharmaceuticals
    Takeda Pharmaceuticals
    Teva
    Advaxis
    ANI Pharmaceuticals
    BHR Pharma
Interested in this report?
Get your sample now!
Table of Content

1 Market Definition
    1.1 Market Segment Overview
    1.2 by Type
    1.3 by End-Use / Application
2 Global Market by Vendors
    2.1 Market Share
    2.2 Vendor Profile
    2.3 Dynamic of Vendors
3 Global Market by Type
    3.1 Market Share
    3.2 Introduction of End-Use by Different Products
4 Global Market by End-Use / Application
    4.1 Market Share
    4.2 Overview of Consumption Characteristics
        4.2.1 Preference Driven
        4.2.2 Substitutability
        4.2.3 Influence by Strategy
        4.2.4 Professional Needs
5 Global Market by Regions
    5.1 Market Share
    5.2 Regional Market Growth
        5.2.1 North America
        5.2.2 Europe
        5.2.3 Asia-Pacific
        5.2.4 South America
        5.2.5 Middle East & Africa
6 North America Market
    6.1 by Type
    6.2 by End-Use / Application
    6.3 by Regions
7 Europe Market
    7.1 by Type
    7.2 by End-Use / Application
    7.3 by Regions
8 Asia-Pacific Market
    8.1 by Type
    8.2 by End-Use / Application
    8.3 by Regions
9 South America Market
    9.1 by Type
    9.2 by End-Use / Application
    9.3 by Regions
10 Middle East & Africa Market
    10.1 by Type
    10.2 by End-Use / Application
    10.3 by Regions
11 Market Forecast
    11.1 Global Market Forecast (2020-2025)
    11.2 Market Forecast by Regions (2020-2025)
    11.3 Market Forecast by Type (2020-2025)
    11.4 Market Forecast by End-Use / Application (2020-2025)
12 Key Manufacturers
    12.Eastman Chemical Astellas Pharma
        12.1.2 Company Overview
        12.1.2 Product and End-User / Application
        12.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
    12.2 Eli Lilly
    12.3 GlaxoSmithKline
    12.4 Sanofi
    12.5 ADC Therapeutics
    12.6 Bayer HealthCare
    12.7 Bristol-Myers Squibb
    12.8 Valeant Pharmaceuticals
    12.9 Endo Pharmaceuticals
    12.10 Foresee Pharmaceuticals
    12.11 Madrigal Pharmaceuticals
    12.12 Merck
    12.13 Novartis
    12.14 Spectrum Pharmaceuticals
    12.15 Takeda Pharmaceuticals
    12.16 Teva
    12.17 Advaxis
    12.18 ANI Pharmaceuticals
    12.19 BHR Pharma
13 Price Overview
    13.1 Price Segment
    13.2 Price Trend
14 Research Conclusion
List of Table


Table Global Benign Prostatic Hyperplasia (BPH) Drugs Market and Growth by Type
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Market and Growth by End-Use / Application
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Million USD) by Vendors (2017-2019)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue Share by Vendors (2017-2019)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Market Volume (Volume) by Vendors (2017-2019)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Market Volume Share by Vendors (2017-2019)
Table Headquarter, Factories & Sales Regions Comparison of Vendors
Table Product List of Vendors
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Market (Million USD) by Type (2017-2019)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Market Share by Type (2017-2019)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Market Volume (Volume) by Type (2017-2019)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Market Volume Share by Type (2017-2019)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Market (Million USD) by End-Use / Application (2017-2019)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Market Share by End-Use / Application (2017-2019)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Market Volume (Volume) by End-Use / Application (2017-2019)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Market Volume Share by End-Use / Application (2017-2019)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Market (Million USD) by Regions (2017-2019)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Market Share by Regions (2017-2019)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Market Volume (Volume) by Regions (2017-2019)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Market Volume Share by Regions (2017-2019)
Table North America Benign Prostatic Hyperplasia (BPH) Drugs Market (Million USD) by Type (2017-2019)
Table North America Benign Prostatic Hyperplasia (BPH) Drugs Market Share by Type (2017-2019)
Table North America Benign Prostatic Hyperplasia (BPH) Drugs Market (Million USD) by End-Use / Application (2017-2019)
Table North America Benign Prostatic Hyperplasia (BPH) Drugs Market Share by End-Use / Application (2017-2019)
Table North America Benign Prostatic Hyperplasia (BPH) Drugs Market (Million USD) by Regions (2017-2019)
Table North America Benign Prostatic Hyperplasia (BPH) Drugs Market Share by Regions (2017-2019)
Table Europe Benign Prostatic Hyperplasia (BPH) Drugs Market (Million USD) by Type (2017-2019)
Table Europe Benign Prostatic Hyperplasia (BPH) Drugs Market Share by Type (2017-2019)
Table Europe Benign Prostatic Hyperplasia (BPH) Drugs Market (Million USD) by End-Use / Application (2017-2019)
Table Europe Benign Prostatic Hyperplasia (BPH) Drugs Market Share by End-Use / Application (2017-2019)
Table Europe Benign Prostatic Hyperplasia (BPH) Drugs Market (Million USD) by Regions (2017-2019)
Table Europe Benign Prostatic Hyperplasia (BPH) Drugs Market Share by Regions (2017-2019)
Table Asia-Pacific Benign Prostatic Hyperplasia (BPH) Drugs Market (Million USD) by Type (2017-2019)
Table Asia-Pacific Benign Prostatic Hyperplasia (BPH) Drugs Market Share by Type (2017-2019)
Table Asia-Pacific Benign Prostatic Hyperplasia (BPH) Drugs Market (Million USD) by End-Use / Application (2017-2019)
Table Asia-Pacific Benign Prostatic Hyperplasia (BPH) Drugs Market Share by End-Use / Application (2017-2019)
Table Asia-Pacific Benign Prostatic Hyperplasia (BPH) Drugs Market (Million USD) by Regions (2017-2019)
Table Asia-Pacific Benign Prostatic Hyperplasia (BPH) Drugs Market Share by Regions (2017-2019)
Table South America Benign Prostatic Hyperplasia (BPH) Drugs Market (Million USD) by Type (2017-2019)
Table South America Benign Prostatic Hyperplasia (BPH) Drugs Market Share by Type (2017-2019)
Table South America Benign Prostatic Hyperplasia (BPH) Drugs Market (Million USD) by End-Use / Application (2017-2019)
Table South America Benign Prostatic Hyperplasia (BPH) Drugs Market Share by End-Use / Application (2017-2019)
Table South America Benign Prostatic Hyperplasia (BPH) Drugs Market (Million USD) by Regions (2017-2019)
Table Middle East & Africa Benign Prostatic Hyperplasia (BPH) Drugs Market Share by Regions (2017-2019)
Table Middle East & Africa Benign Prostatic Hyperplasia (BPH) Drugs Market (Million USD) by Type (2017-2019)
Table Middle East & Africa Benign Prostatic Hyperplasia (BPH) Drugs Market Share by Type (2017-2019)
Table Middle East & Africa Benign Prostatic Hyperplasia (BPH) Drugs Market (Million USD) by End-Use / Application (2017-2019)
Table Middle East & Africa Benign Prostatic Hyperplasia (BPH) Drugs Market Share by End-Use / Application (2017-2019)
Table Middle East & Africa Benign Prostatic Hyperplasia (BPH) Drugs Market (Million USD) by Regions (2017-2019)
Table Middle East & Africa Benign Prostatic Hyperplasia (BPH) Drugs Market Share by Regions (2017-2019)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Market (Million USD) Forecast by Regions (2020-2025)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Market Share Forecast by Regions (2020-2025)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Market Volume (Volume) Forecast by Regions (2020-2025)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Market Volume Share Forecast by Regions (2020-2025)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Market (Million USD) Forecast by Type (2020-2025)
Table Global Benign Prostatic Hyperplasia (BPH) DrugsMarket Share by Forecast Type (2020-2025)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Market (Million USD) Forecast by End-Use / Application (2020-2025)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Market Share Forecast by End-Use / Application (2020-2025)
Table Sales Revenue, Volume, Price, Cost and Margin of Astellas Pharma
Table Sales Revenue, Volume, Price, Cost and Margin of Eli Lilly
Table Sales Revenue, Volume, Price, Cost and Margin of GlaxoSmithKline
Table Sales Revenue, Volume, Price, Cost and Margin of Sanofi
Table Sales Revenue, Volume, Price, Cost and Margin of ADC Therapeutics
Table Sales Revenue, Volume, Price, Cost and Margin of Bayer HealthCare
Table Sales Revenue, Volume, Price, Cost and Margin of Bristol-Myers Squibb
Table Sales Revenue, Volume, Price, Cost and Margin of Valeant Pharmaceuticals
Table Sales Revenue, Volume, Price, Cost and Margin of Endo Pharmaceuticals
Table Sales Revenue, Volume, Price, Cost and Margin of Foresee Pharmaceuticals
Table Sales Revenue, Volume, Price, Cost and Margin of Madrigal Pharmaceuticals
Table Sales Revenue, Volume, Price, Cost and Margin of Merck
Table Sales Revenue, Volume, Price, Cost and Margin of Novartis
Table Sales Revenue, Volume, Price, Cost and Margin of Spectrum Pharmaceuticals
Table Sales Revenue, Volume, Price, Cost and Margin of Takeda Pharmaceuticals
Table Sales Revenue, Volume, Price, Cost and Margin of Teva
Table Sales Revenue, Volume, Price, Cost and Margin of Advaxis
Table Sales Revenue, Volume, Price, Cost and Margin of ANI Pharmaceuticals
Table Sales Revenue, Volume, Price, Cost and Margin of BHR Pharma
List of Figure

Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Market Size (Million USD) 2017-2025
Figure North America Market Growth 2015-2018
Figure Europe Market Growth 2017-2019
Figure Asia-Pacific Market Growth 2017-2019
Figure South America Market Growth 2017-2019
Figure Middle East & Africa Market Growth 2017-2019
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Market (Million USD) and Growth Forecast (2020-2025)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Market Volume (Volume) and Growth Forecast (2020-2025)